This review is a summary of a recent speaker event on new developments in asthma medication the focus of which was international experience with the Fostair, beclometasone dipropionate/formoterol fumarate pressurised inhalation solution.
The presentation was given by Prof. Bruce Thompson of Melbourne, Australia, Prof. Dave Singh of Manchester, UK, and Prof. Alberto Papi of Ferrara, Italy.
Please login below to download this issue (PDF)